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　2015年 1月 26日～4月 27日に株式会社ヘルスアップ
しもふり薬局に来局した患者の中で，本研究の目的に同
















































日本 6 mg/週 16 mg/週　まで
欧米 10–15 mg/週 25–30 mg/週　まで
※海外にて 1週間に 20 mgを超えると副作用が起こりやすいという報告あり
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問 2-2）  前設問（問 2-1）で全て知りたい，自分に関係のありそうなものだけ知りたいと答えた方にお聴きします．
　どのくらいの頻度で繰り返し知らせてほしいですか？
　□ 1週間に 1回　　　　　□半年に 1回
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    A questionnaire survey was conducted by age group to assess changes in attitudes and compliance of patients who 
received an explanation of the serious side effects associated with the intake of Rheumatrex®, as an example, causing 
interstitial pneumonia. Attitude changes towards taking this medication after receiving an explanation of the potential 
side effect of interstitial pneumonia showed that patients of 38.0% in their 20s and 30s felt that they can “safely take 
the medication, as it is supported by concrete data”, whereas patients of 35.3% in their 60s and above had negative 
views saying that they “would rather not take the medication because of being worried”. In other words, this showed a 
declining tendency in compliance with increasing age. Patients of 51.1% in their 60s and above who expressed negative 
views said that they were “still scared of the side effects despite the concrete supporting data”. In other words, patients 
aged 60 years and over become more cautious about side effects than their younger counterparts as they see an increase 
in prescription medication associated with aging and experience increasing side effects due to pharmacokinetic 
changes.
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